On August 4, 2026, a Boston federal jury in Judge Patti B. Saris's courtroom returned the first Covidien hernia-mesh bellwether: $77 million to Larry Patterson and $11 million to Tammy Patterson on consortium. No punitive award. No fraud finding. The compensatory number stood.
On August 4, 2026, a federal jury in Boston filled out the first Covidien hernia-mesh bellwether form and did not cut the compensatory line. Larry Patterson took $77 million. Tammy Patterson took $11 million on a consortium claim. Judge Patti B. Saris took the verdict after a three-week trial in the District of Massachusetts. Insurance Journal reported the finding: failure to warn. Not fraud. Not punitives. The $88 million that remains is compensatory, uncapped.
Larry Patterson, 61, of Etowah County, Alabama, received a Symbotex mesh implant in July 2017 during an incisional-hernia repair by Dr. Lucian Newman. Plaintiffs' counsel told the jury the mesh's porcine collagen coating dissolved far sooner than physicians were led to expect, leaving bare polyester against bowel. The mesh adhered. A second surgery in 2020 took the device out and took inches of intestine with it.
Timothy M. O'Brien of Levin, Papantonio, Proctor, Buchanan, O'Brien, Barr & Mougey led the trial team. Kelsey Stokes of Stokes & Hobbs tried the case with him. "This is a very substantial verdict, but it reflects very substantial damages," O'Brien said. Counsel called it the highest compensatory award in fifteen years of U.S. mesh trials, hernia and transvaginal both. That ranking is counsel's characterization. The verdict form is the number.
Free weekly intelligence for executives responsible for litigation exposure: the named decision-makers, dollar exposure, operating consequence, and next development.
Medtronic, Covidien's parent, said it will challenge the verdict in post-trial motions and on appeal. "We remain confident in Covidien's hernia mesh products, as over the past two decades these products have been used safely and effectively in millions of patients," the company said. Defense counsel argued the coating worked as designed, that the mesh did not cause the bowel obstruction, and that hernia recurrence, surgical choices, obesity, and diabetes explained the injury.
The inventory behind that form is the reason the number travels. About 2,400 federal suits sit consolidated in Boston, including Patterson's. About 7,450 more sit in Massachusetts state court. Counsel put the national plaintiff count against Medtronic hernia lines, including Parietex, ProGrip, and Symbotex, at about 10,350. Other mesh makers, including units of Becton Dickinson and Johnson & Johnson, have largely settled their books. Medtronic is the one that tried first.
Larry Patterson took $77 million. Tammy Patterson took $11 million. The panel capped nothing.
A bellwether is a price signal, not a payment. Medtronic has already said it will move and then appeal. Until a court reduces the figure or a check clears, $77 million and $11 million are what a Boston jury wrote after three weeks of evidence and a charge that left the compensatory line open. The rest of the inventory now has a number to point to. Saris has the post-trial motions.
The Executive Briefing is five questions. It shows you exactly where the gaps are.
Take the Executive Briefing →Free weekly intelligence for executives responsible for litigation exposure: the named decision-makers, dollar exposure, operating consequence, and next development.